You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


Pemphigus

Citations 21-30 of 62 total displayed.

Past content (since Jan 1998):

Studies
A Comparison of Oral Methylprednisolone Plus Azathioprine or Mycophenolate Mofetil for the Treatment of Pemphigus
Stefan Beissert; Thomas Werfel; Uta Frieling; Markus Böhm; Michael Sticherling; Rudolf Stadler; Detlev Zillikens; Berthold Rzany; Nicolas Hunzelmann; Michael Meurer; Harald Gollnick; Thomas Ruzicka; Hans Pillekamp; Volker Junghans; Thomas A. Luger
Arch Dermatol 2006; 142: 1447-1454. [Abstract] [Full text] [PDF]  

Studies
Randomized Controlled Trial of Adjuvant Oral Dexamethasone Pulse Therapy in Pemphigus Vulgaris: PEMPULS Trial
Leon F. Mentink; Maria W. Mackenzie; Gábor G. Tóth; Marianne Laseur; Frank P. G. Lambert; Nic J. G. M. Veeger; Giuseppe Cianchini; Milos D. Pavlovic; Marcel F. Jonkman
Arch Dermatol 2006; 142: 570-576. [Abstract] [Full text] [PDF]  

Observations
Paraneoplastic Pemphigus Associated With Castleman Tumor: A Commonly Reported Subtype of Paraneoplastic Pemphigus in China
Jing Wang; Xuejun Zhu; Ruoyu Li; Ping Tu; Rengui Wang; Lanbo Zhang; Ting Li; Xixue Chen; Aiping Wang; Shuxia Yang; Yan Wu; Haizhen Yang; Suzhen Ji
Arch Dermatol 2005; 141: 1285-1293. [Abstract] [Full text] [PDF]  

Correspondence
Possible Mechanisms in the Induction of Pemphigus Foliaceus by Topical Imiquimod Treatment
Jacob Mashiah; Sarah Brenner
Arch Dermatol 2005; 141: 908-909. [Extract] [Full text] [PDF]  

Correspondence
Possible Mechanisms in the Induction of Pemphigus Foliaceus by Topical Imiquimod Treatment—Reply
Daniel J. Ladd Jr.; Rick J. Lin
Arch Dermatol 2005; 141: 909. [Extract] [Full text] [PDF]  

The Cutting Edge
Successful Treatment of Recalcitrant Pemphigus Vulgaris and Pemphigus Vegetans With Etanercept and Carbon Dioxide Laser
Ming-Hsien Lin; Chao-Kai Hsu; Julia Yu-Yun Lee
Arch Dermatol 2005; 141: 680-682. [Extract] [Full text] [PDF]  

Studies
Dapsone as a Glucocorticoid-Sparing Agent in Maintenance-Phase Pemphigus Vulgaris
Michael R. Heaphy; Joerg Albrecht; Victoria P. Werth
Arch Dermatol 2005; 141: 699-702. [Abstract] [Full text] [PDF]  

Observations
Antibody Titers to Desmogleins 1 and 3 in a Patient With Paraneoplastic Pemphigus Associated With Follicular Dendritic Cell Sarcoma
Mariko Seishima; Makiko Oda; Zuiei Oyama; Tomoaki Yoshimura; Futoshi Yamazaki; Takahiko Aoki; Mariko Nei; Takashi Hashimoto
Arch Dermatol 2004; 140: 1500-1503. [Abstract] [Full text] [PDF]  

Correspondence
Localized Pemphigus Foliaceus Induced by Topical Imiquimod Treatment
Rick Lin; Dan J. Ladd Jr; Doreatha Jean Powell; Bill V. Way
Arch Dermatol 2004; 140: 889-890. [Extract] [Full text] [PDF]  

Observations
Pemphigus Vulgaris Acantholysis Ameliorated by Cholinergic Agonists
Vu Thuong Nguyen; Juan Arredondo; Alexander I. Chernyavsky; Mark R. Pittelkow; Yasuo Kitajima; Sergei A. Grando
Arch Dermatol 2004; 140: 327-334. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7

 Collections
 •Sign up for Topic Collection Alerts
 •Topic Collections Home
 • Show Pemphigus
 collections from JAMA & Archives Journals.
 •Related collections:
  •Dermatologic Disorders
  •Acne
  •Alopecia
  •Bites and Stings
  •Bullous Diseases
  •Connective Tissue Diseases
  •Granulomas
  •Hair Disorders
  •Hemangiomas
  •Herpes
  •Hypersensitivity
  •Nail Diseases
  •Neoplasms
  •Nevi
  •Papillomavirus, Human
  •Pemphigoid
  •Pemphigus
  •Photosensitivity Disorders
  •Pressure Sores
  •Psoriasis
  •Sarcoidosis
  •Sweating
  •Vascular Malformations
  •Wound Healing
  •Dermatologic Disorders, Other
Advertisement





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.